Growth Metrics

Gilead Sciences (GILD) Assets Average (2009 - 2026)

Gilead Sciences posted quarterly Assets Average of $57.7 billion for Q1 2026, little changed year-on-year from $57.7 billion in Q1 2025, and down 1.92% on a QoQ basis from $58.8 billion in Q4 2025.

Gilead Sciences (GILD) has 18 years of Assets Average data on file, last reported at $57.7 billion in Q1 2026.

  • For the quarter ending Q1 2026, Assets Average changed 0.11% year-over-year to $57.7 billion; the trailing twelve-month figure through Mar 2026 stood at $57.7 billion (changed 0.11% YoY), and the FY2025 full-year result was $59.0 billion, down 2.56% from the prior year.
  • Assets Average for Q1 2026 stood at $57.7 billion, down from $58.8 billion in the prior quarter.
  • Across five years, Assets Average topped out at $65.5 billion in Q1 2022 and bottomed at $54.1 billion in Q3 2024.
  • The 5-year median for Assets Average is $59.2 billion (2024), against an average of $59.7 billion.
  • The widest annual swing landed in 2024, when Assets Average decreased 13.32%; it then increased 5.69% in 2025.
  • A 5-year view of Assets Average shows it stood at $62.9 billion in 2022, then decreased by 0.98% to $62.2 billion in 2023, then dropped by 8.82% to $56.8 billion in 2024, then rose by 3.56% to $58.8 billion in 2025, then fell by 1.92% to $57.7 billion in 2026.
  • The last three Assets Average figures came in at $57.7 billion (Q1 2026), $58.8 billion (Q4 2025), and $57.1 billion (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets Avg. (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn - -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn 114.53 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn 200.05 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn 135.21 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn 132.78 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn 91.55 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn 57.65 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn 208.08 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn 88.26 Bn
10 Gsk 88.34 Bn 83.66 Bn - 314.07 Bn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 57.65 Bn
Dec 31, 2025 58.78 Bn
Sep 30, 2025 57.13 Bn
Jun 30, 2025 56.08 Bn
Mar 31, 2025 57.71 Bn
Dec 31, 2024 56.76 Bn
Sep 30, 2024 54.05 Bn
Jun 30, 2024 54.94 Bn
Mar 31, 2024 59.21 Bn
Dec 31, 2023 62.25 Bn
Sep 30, 2023 62.36 Bn
Jun 30, 2023 62.11 Bn
Mar 31, 2023 62.52 Bn
Dec 31, 2022 62.86 Bn
Sep 30, 2022 62.71 Bn
Jun 30, 2022 62.98 Bn
Mar 31, 2022 65.52 Bn
Dec 31, 2021 67.53 Bn
Sep 30, 2021 67.54 Bn
Jun 30, 2021 67.74 Bn
Mar 31, 2021 67.95 Bn
Dec 31, 2020 64.64 Bn
Sep 30, 2020 58.41 Bn
Jun 30, 2020 57.84 Bn
Mar 31, 2020 60.68 Bn
Dec 31, 2019 60.39 Bn
Sep 30, 2019 61.18 Bn
Jun 30, 2019 63.02 Bn
Mar 31, 2019 63.26 Bn
Dec 31, 2018 63.99 Bn
Sep 30, 2018 64.83 Bn
Jun 30, 2018 65.37 Bn
Mar 31, 2018 67.83 Bn
Dec 31, 2017 67.47 Bn
Sep 30, 2017 62.46 Bn
Jun 30, 2017 58.98 Bn
Mar 31, 2017 57.34 Bn
Dec 31, 2016 56.79 Bn
Sep 30, 2016 53.29 Bn
Jun 30, 2016 48.87 Bn
Mar 31, 2016 49.74 Bn
Dec 31, 2015 51.18 Bn
Sep 30, 2015 44.90 Bn
Jun 30, 2015 38.74 Bn
Mar 31, 2015 36.49 Bn
Dec 31, 2014 31.75 Bn
Sep 30, 2014 30.03 Bn
Jun 30, 2014 29.64 Bn
Mar 31, 2014 25.33 Bn
Dec 31, 2013 22.52 Bn
Sep 30, 2013 22.55 Bn
Jun 30, 2013 22.42 Bn
Mar 31, 2013 21.73 Bn
Dec 31, 2012 21.10 Bn
Sep 30, 2012 20.73 Bn
Jun 30, 2012 20.23 Bn
Mar 31, 2012 18.63 Bn
Dec 31, 2011 14.97 Bn
Sep 30, 2011 12.67 Bn
Jun 30, 2011 12.84 Bn
Mar 31, 2011 12.29 Bn
Dec 31, 2010 11.52 Bn
Mar 31, 2010 10.20 Bn
Dec 31, 2009 9.32 Bn
Sep 30, 2009 8.66 Bn